Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2506 in acute ischemic stroke
NCT00229177Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arundic acid in ischemic stroke, sponsored by Ono Pharmaceutical. Started Sep 2005; status: completed.
02
Drugs
arundic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00229177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229177.